147 related articles for article (PubMed ID: 10855258)
41. [Lung scintigraphy with technetium 99m depreotide in the assessment of solitary pulmonary nodules].
Rebollo AC; Jiménez-Hoyuela JM; Martínez del Valle MD; Fernández Aguirre C; Soria C; Velasco JL
Arch Bronconeumol; 2004 Nov; 40(11):534-6. PubMed ID: 15530345
[TBL] [Abstract][Full Text] [Related]
42. Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
Hsu WH; Hsu NY; Shen YY; Yen RF; Kao CH
Cancer Invest; 2003; 21(1):47-52. PubMed ID: 12643009
[TBL] [Abstract][Full Text] [Related]
43. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
[TBL] [Abstract][Full Text] [Related]
44. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
[TBL] [Abstract][Full Text] [Related]
45. 18F-FDG-PET/CT versus 99Tcm-MIBI-SPECT: which is better for detection of solitary pulmonary nodules ?
Xia G; An C; Ming Z; Guo H; Liu L; Li Y
J BUON; 2017; 22(5):1246-1251. PubMed ID: 29135109
[TBL] [Abstract][Full Text] [Related]
46. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
[TBL] [Abstract][Full Text] [Related]
47. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
Divisi D; Barone M; Zaccagna G; Crisci R
Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
[TBL] [Abstract][Full Text] [Related]
48. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
49. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
51. Value of whole-body FDG PET in management of lung cancer.
Higashi K; Matsunari I; Ueda Y; Ikeda R; Guo J; Oguchi M; Tonami H; Yamamoto I
Ann Nucl Med; 2003 Feb; 17(1):1-14. PubMed ID: 12691125
[TBL] [Abstract][Full Text] [Related]
52. PET in lung cancer.
Coleman RE
J Nucl Med; 1999 May; 40(5):814-20. PubMed ID: 10319756
[TBL] [Abstract][Full Text] [Related]
53. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
54. [Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Ruiz-Hernández G; de Juan R; Samanes A; Verea H; Peñas JM; Veres A; Lapeña L; Montz R; Carreras JL
An Med Interna; 2004 Jan; 21(1):12-6. PubMed ID: 15195479
[TBL] [Abstract][Full Text] [Related]
55. The value of ¹⁸F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis.
Li Y; Su M; Li F; Kuang A; Tian R
Ann Nucl Med; 2011 Dec; 25(10):804-11. PubMed ID: 21879296
[TBL] [Abstract][Full Text] [Related]
56. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.
Mavi A; Lakhani P; Zhuang H; Gupta NC; Alavi A
Radiol Clin North Am; 2005 Jan; 43(1):1-21, ix. PubMed ID: 15693644
[TBL] [Abstract][Full Text] [Related]
57. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B
Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290
[TBL] [Abstract][Full Text] [Related]
58. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
59. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
Spadafora M; Evangelista L; Gridelli C; Cuocolo A
Eur J Radiol; 2017 May; 90():188-191. PubMed ID: 28583632
[TBL] [Abstract][Full Text] [Related]
60. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]